Brian Henry

443 total citations
6 papers, 215 citations indexed

About

Brian Henry is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Brian Henry has authored 6 papers receiving a total of 215 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 1 paper in Hematology. Recurrent topics in Brian Henry's work include Ubiquitin and proteasome pathways (4 papers), Peptidase Inhibition and Analysis (3 papers) and Protein Degradation and Inhibitors (3 papers). Brian Henry is often cited by papers focused on Ubiquitin and proteasome pathways (4 papers), Peptidase Inhibition and Analysis (3 papers) and Protein Degradation and Inhibitors (3 papers). Brian Henry collaborates with scholars based in United States, Canada and Singapore. Brian Henry's co-authors include Simon Ng, Anthony W. Partridge, Shuhui Lim, Shih Chieh Chang, Greg L. Beilhartz, David P. Lane, Charles W. Johannes, Christopher J. Brown, Roman A. Melnyk and Pooja Gopal and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Scientific Reports.

In The Last Decade

Brian Henry

6 papers receiving 212 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian Henry United States 5 192 90 24 22 21 6 215
Gabriel M. C. Longo Germany 5 128 0.7× 22 0.2× 12 0.5× 22 1.0× 15 0.7× 8 156
Christopher Del Nagro France 3 92 0.5× 71 0.8× 17 0.7× 25 1.1× 5 0.2× 3 148
Stephanie H. Cholensky United States 11 389 2.0× 88 1.0× 13 0.5× 21 1.0× 36 1.7× 20 432
Matthew Gumbleton United States 6 119 0.6× 41 0.5× 10 0.4× 97 4.4× 15 0.7× 9 209
Valdemaras Petrosius Denmark 7 175 0.9× 44 0.5× 6 0.3× 13 0.6× 6 0.3× 9 233
Melissa Gallery United States 6 69 0.4× 64 0.7× 20 0.8× 10 0.5× 6 0.3× 7 105
Robert Holgate United Kingdom 6 82 0.4× 43 0.5× 57 2.4× 56 2.5× 5 0.2× 6 139
Jenni Cryan United Kingdom 5 140 0.7× 90 1.0× 7 0.3× 32 1.5× 28 1.3× 7 173
Helen X Chen United States 6 68 0.4× 71 0.8× 6 0.3× 21 1.0× 21 1.0× 8 127
Tomoko Asatsuma‐Okumura Japan 6 244 1.3× 77 0.9× 5 0.2× 11 0.5× 133 6.3× 9 294

Countries citing papers authored by Brian Henry

Since Specialization
Citations

This map shows the geographic impact of Brian Henry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Henry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Henry more than expected).

Fields of papers citing papers by Brian Henry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Henry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Henry. The network helps show where Brian Henry may publish in the future.

Co-authorship network of co-authors of Brian Henry

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Henry. A scholar is included among the top collaborators of Brian Henry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Henry. Brian Henry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Ng, Simon, Shuhui Lim, Ruban Mangadu, et al.. (2022). STUB1 is an intracellular checkpoint for interferon gamma sensing. Scientific Reports. 12(1). 14087–14087. 4 indexed citations
2.
Chang, Shih Chieh, Pooja Gopal, Shuhui Lim, et al.. (2022). Targeted degradation of PCNA outperforms stoichiometric inhibition to result in programed cell death. Cell chemical biology. 29(11). 1601–1615.e7. 19 indexed citations
3.
Ng, Simon, Alexander C. Brueckner, Qiaolin Deng, et al.. (2022). Discovery and Structure-Based Design of Macrocyclic Peptides Targeting STUB1. Journal of Medicinal Chemistry. 65(14). 9789–9801. 10 indexed citations
4.
Lim, Shuhui, Shih Chieh Chang, Simon Ng, et al.. (2020). bioPROTACs as versatile modulators of intracellular therapeutic targets including proliferating cell nuclear antigen (PCNA). Proceedings of the National Academy of Sciences. 117(11). 5791–5800. 107 indexed citations
5.
Lim, Shuhui, Yu‐Chi Juang, Pooja Gopal, et al.. (2020). Exquisitely Specific anti-KRAS Biodegraders Inform on the Cellular Prevalence of Nucleotide-Loaded States. ACS Central Science. 7(2). 274–291. 55 indexed citations
6.
Hamilton, B. JoNell, Xiaowei Wang, Jane Collins, et al.. (2008). Separate cis-trans Pathways Post-transcriptionally Regulate Murine CD154 (CD40 Ligand) Expression. Journal of Biological Chemistry. 283(37). 25606–25616. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026